Protagenic Therapeutics Market Cap

Protagenic Therapeutics has a market cap or net worth of $811.84 thousand as of March 6, 2026.

Market Cap

811.84K

Enterprise Value

2.09M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.42

Market Cap Chart

Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 811.84K, a decrease of -91.58%. That is a compound annual growth rate of -95.56%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	811.84K	-67.72%
Dec 31, 2025	2.52M	-73.91%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Emmaus Life Sciences	1.02M
Sorrento Therapeutics	1.03M
Avenue Therapeutics	880.66K
Eastgate Biotech	1.06M
EV Biologics	840.53K
International Stem Cell	1.13M
CERo Therapeutics Holdings	1.14M
Evofem Biosciences	1.15M

Market Cap Rankings